Building on insights from last year, experts across sessions at the 2026 American Academy of Dermatology (AAD) Annual Meeting ...

Overall, mammography prevalence declined from 69.9% to 59.2% among women aged 40 to 49 years and from 81.3% to 77.0% in women ...

ATTAIN demonstrated placebo-adjusted weight reductions of roughly 9–11 percentage points at 72 weeks, with 27.3 lb (12.4%) ...

From teledermatology billing to rural outreach and transplant advances, new studies and presentations reveal shifts in access ...

Metabolic dysfunction-associated steatohepatitis (MASH) places a significant burden on the lives of patients, but a proactive ...

HB 4965 permits switching to an alternative medically appropriate treatment of equal or lesser value after initial approval, ...

The CDC announced on April 1 that they would be downsizing their operations, leading to the pause of diagnostic testing for mpox, rabies, and more than 2 dozen other infectious diseases. 1 The CDC has ...

Collapsing the very-low-risk category reflects broader acceptance of active surveillance for Gleason 6 disease, while PARP ...

“Interestingly, BIRC5 and MCL-1 have both been reported to be over-expressed and strongly correlated with progression and ...

Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack ...

In this Q&A with The American Journal of Managed Care® ( AJMC® ), panelist Turab Mohammed, MD, a hematologist-oncologist at ...

Lauren Madigan, MD, shares open-label extension results demonstrating sustained improvements with avapritinib in patients ...